Kamada Pharmaceuticals

Kamada Pharmaceuticals

Investors & Media

Investor Kit

Notice and Proxy Statement for the 2020 Annual General Meeting of Shareholders
Download and review the notice and proxy statement for Kamada 2020 annual general meeting of Shareholders, to be held at December 10, 2020.
Company Presentation
Click here for latest company slidedeck
Kamada Logo

Join Our Mailing List

Sign up to receive Email updates from Kamada

Latest News

Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in Children

Jun. 2, 2021

This website uses cookies to track the site’s performance and improve user experience.

By using our website you consent to all cookies in accordance with our Privacy Policy.

Font Resize

Contrast

Accessibility by WAH